Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI025617-04
Application #
2063033
Study Section
Special Emphasis Panel (SRC (49))
Project Start
1987-09-30
Project End
1991-04-30
Budget Start
1990-09-01
Budget End
1991-04-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
U.S. Army Fort Detrick
Department
Type
DUNS #
City
Frederick
State
MD
Country
United States
Zip Code
21701
Black, P l; Ussery, M A; Barney, S et al. (1996) Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice. Antiviral Res 29:175-86
Black, P L; McKinnon, K M; Wooden, S L et al. (1996) Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT. Int J Immunopharmacol 18:633-50
Buckheit Jr, R W; Germany-Decker, J; Hollingshead, M G et al. (1993) Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents. AIDS Res Hum Retroviruses 9:1097-106
Klinman, D M; Krieg, A; Conover, J et al. (1992) Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS. AIDS Res Hum Retroviruses 8:101-6
Hersh, E M (1992) Immunomodulatory drugs of relevance to the management of microbial infections. Adv Exp Med Biol 319:1-11
Hersh, E M; Gschwind, C R; Taylor, C W et al. (1992) Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro. J Natl Cancer Inst 84:1238-44
Morse, D E; Evoniuk, G; Black, P L et al. (1992) Neuropathologies associated with dideoxycytosine: a preliminary assessment. Ann N Y Acad Sci 648:312-6
Buckheit Jr, R W; White, E L; Shannon, W M et al. (1992) Significant anti-HIV activity of new modified polyanionic polymers in vitro. Immunopharmacol Immunotoxicol 14:707-21
Hersh, E M (1991) Current status of immunotherapy of patients with HIV-infection. Int J Immunopharmacol 13 Suppl 1:9-18
White, E L; Buckheit Jr, R W; Ross, L J et al. (1991) A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res 16:257-66

Showing the most recent 10 out of 12 publications